Balance Sheet for Harvard Bioscience Inc. (HBIO)

$ 3.74   -0.03 (-0.80%) Volume: 160.11k 4:00 PM EST Nov 23, 2020
After Hours:  $ 3.74 0.00 (0.00%) Volume: 1.31k 4:00 PM EST Nov 23, 2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 8,335 8,173 5,192 5,596 6,744
Restrictable Cash - - - - -
Marketable Securities - - - - -
Accounts Receivable 20,704 21,463 13,382 15,746 17,547
Loans Receivable - - - - -
Other Receivables 7,105 3,109 3,709 4,175 3,873
Receivables 20,704 21,463 17,091 19,921 21,420
Inventories, Raw Materials 13,347 14,484 10,027 9,792 10,498
Inventories, Work in Progress 3,153 3,667 1,042 823 888
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 5,561 6,936 5,779 9,340 10,957
Inventories, Other 22,061 25,087 16,848 19,955 22,343
Inventories, Adjustments & Allowances - - - - -
Inventories 22,061 25,087 16,848 19,955 22,343
Prepaid Expenses - - - - -
Current Deferred Income Taxes - - - - 42
Other Current Assets 2,472 3,109 - - -
Total Current Assets 53,572 57,832 47,535 45,472 50,549
Land and Improvements - - - - -
Buildings and Improvement 2,151 2,468 - - -
Machinery, Furniture and Equipment 17,565 20,868 17,100 16,809 19,095
Construction in Progress - - - - -
Fixed Assets, Other 8,463 - 2,197 2,095 2,825
Fixed Assets, Total 28,179 23,336 19,297 18,904 21,920
Gross Fixed Assets 28,179 23,336 19,297 18,904 21,920
Accumulated Depreciation (14,940) (17,438) (15,554) (14,608) (16,018)
Net Fixed Assets 13,239 5,898 3,743 4,296 5,902
Intangibles 38,405 45,764 11,274 18,680 22,095
Cost in Excess 57,381 57,304 36,336 38,032 40,357
Non-Current Deferred Income Taxes 418 211 182 1,157 995
Other Non-Current Assets 2,273 1,815 10,284 128 152
Total Non-Current Assets 111,298 110,781 61,819 62,293 69,501
Total Assets 164,870 168,613 109,354 107,765 120,050
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 5,339 7,359 4,410 6,196 8,782
Short Term Debt 9,324 5,982 2,765 2,372 2,364
Notes Payable - - - - -
Accrued Expenses 1,072 1,407 3,130 4,550 4,021
Accrued Liabilities 1,072 1,407 3,130 4,550 4,021
Deferred Revenues 3,949 3,820 815 500 752
Current Deferred Income Taxes (398) (2,861) (1,584) (279) 15,116
Other Current Liabilities 5,628 6,921 2,921 983 1,158
Total Current Liabilities 25,312 25,489 14,041 14,601 19,323
Long Term Debt 46,917 54,813 8,983 11,374 16,369
Deferred Income Tax 1,974 2,301 2,653 6,417 3,775
Other Non-Current Liabilities 749 3,286 2,777 3,177 2,985
Minority Interest - - - - -
Capital Lease Obligations 8,224 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 57,864 60,400 14,413 20,968 23,129
Total Liabilities 83,176 85,889 28,454 35,569 42,452
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 81,694 82,724 80,900 72,196 77,598
Common Par 438 436 419 418 416
Additional Paid in Capital 229,189 226,377 218,792 215,134 211,457
Cumulative Translation Adjustments - - - - -
Retained Earnings (124,576) (119,889) (116,967) (116,030) (111,723)
Treasury Stock 10,668 10,668 10,668 10,668 10,668
Other Equity Adjustments (12,689) (13,532) (10,676) (16,658) (11,884)
Total Capitalization 128,611 137,537 89,883 83,570 93,967
Total Equity 81,694 82,724 80,900 72,196 77,598
Total Liabilities & Shareholder's Equity 164,870 168,613 109,354 107,765 120,050
Cash Flow (4,687) (2,922) (865) (4,307) (19,039)
Working Capital 28,260 32,343 33,494 30,871 31,226
Free Cash Flow 6,829 1,898 128 3,904 (2,273)
Invested Capital 128,611 137,537 89,883 83,570 93,967
Shares Outstanding - Common Class Only 38,188 37,379 35,018 34,441 33,979
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 38,188 37,379 35,018 34,441 33,979
Total Common Shares Outstanding 38,188 37,379 35,018 34,441 33,979
Treasury Shares 7,746 7,746 7,746 7,746 7,746
Basic Weighted Shares Outstanding 37,814 36,453 34,753 34,212 33,593
Diluted Weighted Shares Outstanding 37,814 36,453 34,753 34,212 33,593